Boston Biotech Dash Bio Expands with New Lab in Waltham

The company's new 24,000-square-foot facility represents a fivefold increase in its footprint.

Published on Feb. 10, 2026

Got story updates? Submit your updates here. ›

Dash Bio, a Boston-based biotech company, has opened a new 24,000-square-foot laboratory facility in Waltham, Massachusetts. The expansion represents a significant increase in the company's capacity, allowing for more sample storage, instrumentation, and automated workflows to support its contracted bioanalysis research for the life sciences industry.

Why it matters

The opening of Dash Bio's new Waltham lab is a sign of the continued growth and expansion of the Boston-area biotech industry. As a hub for life sciences research and development, the region has seen increased demand for specialized lab space to support the work of biotech firms.

The details

Dash Bio, which was founded in 2024, previously had its primary lab located in downtown Boston. The new 24,000-square-foot facility in Waltham represents a fivefold increase in the company's footprint, allowing it to expand its capacity for sample storage, instrumentation, and automated workflows to support its contracted bioanalysis research.

  • Dash Bio was founded in 2024.
  • The new Waltham lab opened in February 2026.

The players

Dash Bio

A Boston-based biotech company that performs contracted bioanalysis research for the life sciences industry.

Boston Real Estate Times

The publication that reported on Dash Bio's expansion into Waltham.

Got photos? Submit your photos here. ›

The takeaway

The expansion of Dash Bio's operations into Waltham is a testament to the continued growth and vitality of the Boston-area biotech industry, which has become a hub for life sciences research and development. The new lab facility will allow the company to increase its capacity and support the growing demand for specialized bioanalysis services in the region.